Advancements in Bruton’s Tyrosine Kinase Inhibitors in...

added blog Health

2025-09-25 09:54:56

Advancements in Bruton’s Tyrosine Kinase Inhibitors in Oncology and Immunology

The BTK Inhibitors Market has experienced significant growth in recent years, driven by their expanding role in treating blood cancers and autoimmune disorders. Bruton’s tyrosine kinase (BTK) is a key enzyme in B-cell receptor signaling, making it a prime target for therapeutic intervention. By inhibiting BTK, these treatments offer new solutions for patients with conditions such as...

0 Comments 0 Shares 670 Views 0 Reviews